Literature DB >> 11341047

A protective role of dietary vitamin D3 in rat colon carcinogenesis.

E Mokady1, B Schwartz, S Shany, S A Lamprecht.   

Abstract

The aim of the present work was to gain insight into a putative anticancer effect of dietary vitamin D3 (cholecalciferol) in a rat model of colon carcinogenesis. Male rats were assigned to three different dietary groups. The dietary regimens were based on a standard murine-defined diet (AIN-76A) or a stress diet containing 20% fat, reduced Ca2+ concentration, a high phosphorus-to-Ca2+ ratio, and either low or high vitamin D3 content. Colorectal cancer was induced by administration of the procarcinogen 1,2-dimethylhydrazine (DMH). Blood Ca2+, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], and 25-hydroxyvitamin D3 [25(OH)D3] levels were measured in DMH-treated rats and in respective weight- and age-matched dietary control groups. Colonic epithelial proliferation was assessed by determining thymidine kinase (TK) activity, bromodeoxyuridine (BrdUrd) incorporation into crypt cell DNA, and the mean labeling index along the colonic crypt continuum. Maintenance of rats on the stress diet either unmodified or supplemented with vitamin D3 in the absence of carcinogen treatment provoked a time-dependent rise in colonic TK activity and hyperproliferation of colonic epithelium. DMH treatment of rats maintained on the standard diet caused a marked increase in the proliferative indexes of colonic epithelium and in expansion of the crypt proliferative compartment. TK activity and the crypt mitotic zone were significantly augmented in the animal group fed the stress diet. Supplementary vitamin D3 abrogated the stress diet-enhanced colonic responses to the carcinogenic insult. Colon tumor multiplicity was fourfold higher in animals fed the stress diet than in animals maintained on a standard diet. The marked rise in colonic tumor multiplicity and adenocarcinoma incidence in rats fed the stress diet was obliterated by supplemental dietary vitamin D3. Cumulatively, the present results indicate that dietary vitamin D3 impedes the neoplastic process in murine large intestine and strengthen the view that inappropriate changes in dietary components and micronutrients are contributory determinants of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11341047     DOI: 10.1207/S15327914NC381_10

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  14 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

Review 2.  Novel Hedgehog pathway targets against basal cell carcinoma.

Authors:  Jean Y Tang; Po-Lin So; Ervin H Epstein
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-21       Impact factor: 4.219

Review 3.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

4.  Thymoquinone potentiates chemoprotective effect of Vitamin D3 against colon cancer: a pre-clinical finding.

Authors:  Amr M Mohamed; Bassem A Refaat; Adel G El-Shemi; Osama A Kensara; Jawwad Ahmad; Shakir Idris
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas.

Authors:  Jean Y Tang; Tony Zheng Xiao; Yuko Oda; Kris S Chang; Elana Shpall; Angela Wu; Po-Lin So; Jennifer Hebert; Daniel Bikle; Ervin H Epstein
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-24

Review 6.  Calcium, calcium-sensing receptor and growth control in the colonic mucosa.

Authors:  James Varani
Journal:  Histol Histopathol       Date:  2011-06       Impact factor: 2.303

7.  Parathormone and 1,25(OH)2D3 but not 25(OH)D3 serum levels, in an inverse correlation, reveal an association with advanced stages of colorectal cancer.

Authors:  Anestis Charalampopoulos; Alexander Charalabopoulos; Anna Batistatou; Christos Golias; Antonia Anogeianaki; Dimitrios Peschos; Iosif Iliadis; Anastasios Macheras; Konstantinos Charalabopoulos
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

8.  Growth-inhibitory effects of a mineralized extract from the red marine algae, Lithothamnion calcareum, on Ca(2+)-sensitive and Ca(2+)-resistant human colon carcinoma cells.

Authors:  Muhammad Nadeem Aslam; Narasimharao Bhagavathula; Tejaswi Paruchuri; Xin Hu; Subhas Chakrabarty; James Varani
Journal:  Cancer Lett       Date:  2009-04-24       Impact factor: 8.679

9.  Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.

Authors:  Magdalena Milczarek; Beata Filip-Psurska; Wiesław Swiętnicki; Andrzej Kutner; Joanna Wietrzyk
Journal:  Oncol Rep       Date:  2014-06-11       Impact factor: 3.906

10.  Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis.

Authors:  Doris Maria Hummel; Ursula Thiem; Julia Höbaus; Ildiko Mesteri; Lukas Gober; Caroline Stremnitzer; João Graça; Barbara Obermayer-Pietsch; Enikö Kallay
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-11       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.